Haemonetics Corporation (HAE) Operating Margin
- Operating margin · 12 months: Value 11.86%; Formula and calculation Operating income / revenue. Period ending 2026-06-27..
Operating margin
Overview →Financial period ending 2026-06-27; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | 11.86% | Operating income / revenue. Period ending 2026-06-27. $160.32M ÷ $1.35B × 100 ≈ 11.86% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | 160.32M USD | Operating Income (Loss) |
| Revenue | 1.35B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | 553.87M USD | Cost of Goods and Services Sold |
| Research and development | 59.70M USD | Research and Development Expense |
| Selling, general and administration | 450.64M USD | Selling, General and Administrative Expense |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-27 | $160.32M | $1.35B | $553.87M | $59.70M | $450.64M | 11.86% |
| 2026-03-28 | $156.73M | $1.33B | $546.44M | $59.77M | $442.42M | 11.75% |
| 2025-12-27 | $251.09M | $1.32B | $535.85M | $63.63M | $436.62M | 19.05% |
| 2025-09-27 | $242.73M | $1.33B | $554.26M | $65.27M | $433.93M | 18.28% |
| 2025-06-28 | $235.93M | $1.35B | $579.77M | $64.53M | $439.26M | 17.53% |
| 2025-03-29 | $221.82M | $1.36B | $611.87M | $62.72M | $436.79M | 16.30% |
| 2024-12-28 | $180.43M | $1.37B | $641.70M | $62.66M | $432.92M | 13.14% |
| 2024-09-28 | $167.37M | $1.36B | $645.09M | $60.10M | $438.17M | 12.30% |
| 2024-06-29 | $150.98M | $1.33B | $634.69M | $56.24M | $446.54M | 11.32% |
| 2024-03-30 | $164.88M | $1.31B | $617.51M | $54.44M | $431.78M | 12.60% |
| 2023-12-30 | $170.19M | (m) | $598.29M | $54.22M | $407.86M | (m) |
| 2023-09-30 | $167.50M | (m) | $586.50M | $53.65M | $390.81M | (m) |
| 2023-07-01 | $178.93M | (m) | $578.43M | $51.88M | $377.93M | (m) |
| 2023-04-01 | $156.03M | (m) | $553.56M | $50.13M | $376.68M | (m) |
| 2022-12-31 | $139.98M | (m) | $534.09M | $47.70M | $371.14M | (m) |
| 2022-10-01 | $132.35M | (m) | $508.70M | $45.05M | $357.20M | (m) |
| 2022-07-02 | $110.13M | (m) | $486.45M | $45.00M | $340.57M | (m) |
| 2022-04-02 | $80.75M | (m) | $487.69M | $46.80M | $339.56M | (m) |
| 2022-01-01 | $40.38M | (m) | $502.23M | $44.43M | $330.41M | (m) |
| 2021-10-02 | $45.15M | (m) | $501.13M | $41.90M | $315.32M | (m) |
| 2021-07-03 | $79.42M | (m) | $487.52M | $37.81M | $303.10M | (m) |
| 2021-04-03 | $89.75M | (m) | $472.63M | $32.86M | $274.19M | (m) |
| 2020-12-26 | $136.93M | (m) | $454.34M | $30.99M | $285.17M | (m) |
| 2020-09-26 | $137.41M | (m) | $465.14M | $30.49M | $289.99M | (m) |
| 2020-06-27 | $128.37M | (m) | $486.97M | $31.15M | $296.22M | (m) |
| 2020-03-28 | $103.35M | (m) | $503.97M | $30.88M | $299.68M | (m) |
| 2019-12-28 | $101.20M | (m) | $517.12M | $30.66M | $299.71M | (m) |
| 2019-09-28 | $88.61M | (m) | $522.38M | $32.63M | $295.32M | (m) |
| 2019-06-29 | $64.95M | (m) | $526.49M | $33.80M | $302.73M | (m) |
| 2019-03-30 | $83.55M | (m) | $550.04M | $35.71M | $298.28M | (m) |
| 2018-12-29 | $73.96M | (m) | (m) | $38.05M | $298.69M | (m) |
| 2018-09-29 | $46.66M | (m) | (m) | $41.50M | $322.67M | (m) |
| 2018-06-30 | $44.84M | (m) | (m) | $40.44M | $318.21M | (m) |
| 2018-03-31 | $56.16M | (m) | (m) | $39.23M | $316.52M | (m) |
| 2017-12-30 | $-15.62M | (m) | (m) | $37.46M | $309.20M | (m) |
| 2017-09-30 | $4.58M | (m) | (m) | $33.50M | $282.75M | (m) |
| 2017-07-01 | $5.11M | (m) | (m) | $34.31M | $281.09M | (m) |
| 2017-04-01 | $-19.38M | (m) | (m) | $37.56M | $301.73M | (m) |
| 2016-12-31 | $32.58M | (m) | (m) | $39.38M | $304.92M | (m) |
| 2016-10-01 | $-49.81M | (m) | (m) | $41.86M | $313.66M | (m) |
| 2016-07-02 | $-55.43M | (m) | (m) | $45.08M | $317.11M | (m) |
| 2016-04-02 | $-43.94M | (m) | (m) | $44.97M | $317.22M | (m) |
| 2015-12-26 | $-26.85M | (m) | (m) | $51.04M | $315.81M | (m) |
| 2015-09-26 | $52.58M | (m) | (m) | $50.74M | $319.10M | (m) |
| 2015-06-27 | $45.81M | (m) | (m) | $50.13M | $329.30M | (m) |
| 2015-03-28 | $40.54M | $910.37M | (m) | $54.19M | $334.25M | 4.45% |
| 2014-12-27 | $41.65M | (m) | (m) | $50.80M | $347.34M | (m) |
| 2014-09-27 | $41.25M | (m) | (m) | $54.36M | $354.14M | (m) |
| 2014-06-28 | $52.27M | (m) | (m) | $58.37M | $350.88M | (m) |
| 2014-03-29 | $47.33M | $938.51M | (m) | $54.20M | $365.13M | 5.04% |
| 2013-12-28 | $52.39M | (m) | (m) | $53.94M | $365.49M | (m) |
| 2013-09-28 | $50.28M | (m) | (m) | $50.31M | $362.71M | (m) |
| 2013-06-29 | $36.75M | (m) | (m) | $46.19M | $362.24M | (m) |
| 2013-03-30 | $56.44M | $891.99M | (m) | $44.39M | $323.05M | 6.33% |
| 2012-12-29 | $59.69M | (m) | (m) | $39.43M | $300.48M | (m) |
| 2012-09-29 | $69.26M | (m) | (m) | $38.08M | $275.08M | (m) |
| 2012-06-30 | $77.93M | (m) | (m) | $37.60M | $256.65M | (m) |
| 2012-03-31 | $88.76M | $727.84M | (m) | $36.80M | $245.26M | 12.19% |
| 2011-12-31 | $96.69M | (m) | (m) | $36.98M | $230.04M | (m) |
| 2011-10-01 | $99.93M | (m) | (m) | $35.74M | $225.60M | (m) |
| 2011-07-02 | $110.27M | (m) | (m) | $33.34M | $215.78M | (m) |
| 2011-04-02 | $110.55M | (m) | (m) | $32.66M | $213.90M | (m) |
| 2011-01-01 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-10-02 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-07-03 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-04-03 | $83.28M | (m) | (m) | $26.38M | $214.48M | (m) |
| 2009-12-26 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-09-26 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-06-27 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-03-28 | $85.57M | (m) | (m) | $23.86M | $198.74M | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |